| scholarly article | Q13442814 |
| P50 | author | Alison Goate | Q45660395 |
| Silva Hecimovic | Q56832004 | ||
| P2093 | author name string | Jun Wang | |
| Georgia Dolios | |||
| Rong Wang | |||
| Maribel Martinez | |||
| P2860 | cites work | Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity | Q22010912 |
| Purification and cloning of amyloid precursor protein beta-secretase from human brain | Q22010914 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 205-218 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Neurobiology of Disease | Q15716606 |
| P1476 | title | Mutations in APP have independent effects on Abeta and CTFgamma generation | |
| P478 | volume | 17 |
| Q37081815 | A TAG on to the neurogenic functions of APP |
| Q37083598 | A helix-to-coil transition at the epsilon-cut site in the transmembrane dimer of the amyloid precursor protein is required for proteolysis |
| Q37678589 | A novel PSEN1 mutation (I238M) associated with early-onset Alzheimer's disease in an African-American woman |
| Q34683369 | A synthetic antibody fragment targeting nicastrin affects assembly and trafficking of γ-secretase |
| Q40387366 | APP substitutions V715F and L720P alter PS1 conformation and differentially affect Abeta and AICD generation |
| Q42674921 | APP-BP1 inhibits Abeta42 levels by interacting with Presenilin-1. |
| Q60313667 | Alzheimer's disease |
| Q37195665 | Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio |
| Q36380671 | Alzheimer's disease-causing proline substitutions lead to presenilin 1 aggregation and malfunction. |
| Q37389332 | Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. |
| Q40077211 | Amyloid beta-protein precursor juxtamembrane domain regulates specificity of gamma-secretase-dependent cleavages |
| Q31088092 | Amyloid-β metabolism in Niemann-Pick C disease models and patients |
| Q43198294 | An APP inhibitory domain containing the Flemish mutation residue modulates gamma-secretase activity for Abeta production |
| Q92596034 | Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors |
| Q34555722 | Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation |
| Q33785336 | Cholesterol accumulation in Niemann Pick type C (NPC) model cells causes a shift in APP localization to lipid rafts |
| Q56769946 | Conserved residues in juxtamembrane region of the extracellular domain of nicastrin are essential for gamma-secretase complex formation |
| Q38101383 | Development and mechanism of γ-secretase modulators for Alzheimer's disease |
| Q30512265 | Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease |
| Q51808780 | Equimolar production of amyloid beta-protein and amyloid precursor protein intracellular domain from beta-carboxyl-terminal fragment by gamma-secretase. |
| Q51052529 | Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheim |
| Q27681185 | Familial Alzheimer’s mutations within APPTM increase Aβ42 production by enhancing accessibility of ε-cleavage site |
| Q40377263 | Identification of putative SNPs in progressive retinal atrophy affected Canis lupus familiaris using exome sequencing |
| Q37431194 | Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production |
| Q40183194 | Insulysin cleaves the APP cytoplasmic fragment at multiple sites. |
| Q35246412 | Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease |
| Q35768842 | Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity. |
| Q35562694 | Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid β peptide length: support for a sequential model of γ-secretase intramembrane proteolysis and regulation by the amyloid β precursor protein (APP) juxtamembrane re |
| Q41843325 | Major carboxyl terminal fragments generated by γ-secretase processing of the Alzheimer amyloid precursor are 50 and 51 amino acids long |
| Q33515793 | Modulation of gamma-secretase specificity using small molecule allosteric inhibitors |
| Q38001784 | Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease |
| Q34352043 | Mutation Analysis of the Presenilin 1 N-terminal Domain Reveals a Broad Spectrum of γ-Secretase Activity toward Amyloid Precursor Protein and Other Substrates |
| Q41899989 | Niemann-Pick type C cells show cholesterol dependent decrease of APP expression at the cell surface and its increased processing through the beta-secretase pathway |
| Q38248506 | Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer's disease management |
| Q36109130 | Presenilin function and gamma-secretase activity |
| Q36481949 | Presenilin-1 280Glu-->Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer's disease |
| Q28817811 | Presenilin/gamma-secretase cleaves CD46 in response to Neisseria infection |
| Q34110227 | Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process |
| Q39912930 | S-palmitoylation of gamma-secretase subunits nicastrin and APH-1 |
| Q41126914 | Stable insertion of Alzheimer Abeta peptide into the ER membrane strongly correlates with its length |
| Q52620416 | The genes associated with early-onset Alzheimer's disease. |
| Q37961985 | The physiology of the β-amyloid precursor protein intracellular domain AICD. |
Search more.